Drug establishmentActive, Registered FY2026FDA warning letter on file

Liebel-Flarsheim Company LLC

Liebel-Flarsheim Company LLC is an FDA-registered drug establishment (FEI 1028892) located in , North Carolina. The facility is active, registered for FY2026. FDA has issued 1 warning letter(s) to this facility.

FDA warning letter

Oct 17, 2025

CGMP/Finished Pharmaceuticals/Adulterated

Read the letter on FDA.gov ›

A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.

Establishment record

FEI Number

1028892

Address

8800 Durant Road, , North Carolina

Establishment type

Drug establishment

Products / operations

ANALYSIS; LABEL; MANUFACTURE; PACK

Registration status

Active, Registered FY2026

Verify this record on FDA.gov ›

Inspection history

Inspections on file

None on file

Form 483 observations

None on file

FDA publishes only a subset of inspection records and Form 483s, so "None on file" is not a guarantee of a clean inspection history.

Questions

Is Liebel-Flarsheim Company LLC registered with the FDA?

Yes. Liebel-Flarsheim Company LLC is an FDA-registered drug establishment (FEI 1028892) in , North Carolina. Its current registration status is Active, Registered FY2026.

Has Liebel-Flarsheim Company LLC received an FDA warning letter?

Yes. FDA issued a warning letter to Liebel-Flarsheim Company LLC; the most recent is dated Oct 17, 2025 (CGMP/Finished Pharmaceuticals/Adulterated).

What does Liebel-Flarsheim Company LLC do?

Liebel-Flarsheim Company LLC's FDA-registered operations are: ANALYSIS; LABEL; MANUFACTURE; PACK.

Related facilities

GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD Acme United Corporation Dixon Investments Inc MERICON INDUSTRIES, INC.Scientific Protein Laboratories LLC Wisconsin Pharmacal Company, LLC

Source: FDA public data · status as of 2026-06-01